Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese
Eng‐King Tan, Celia Ia Choo Tan, Stephanie Fook‐Chong, et al.
Journal of the Neurological Sciences (2003) Vol. 216, Iss. 1, pp. 163-167
Closed Access | Times Cited: 187

Showing 26-50 of 187 citing articles:

Tea and human health: biomedical functions of tea active components and current issues
Zongmao Chen, Zhi Lin
Journal of Zhejiang University SCIENCE B (2015) Vol. 16, Iss. 2, pp. 87-102
Open Access | Times Cited: 92
The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
Chien‐Tai Hong, Lung Chan, Chyi‐Huey Bai
Nutrients (2020) Vol. 12, Iss. 6, pp. 1860-1860
Open Access | Times Cited: 90
Health Consciousness, Food Safety Concern, and Consumer Purchase Intentions Toward Organic Food: The Role of Consumer Involvement and Ecological Motives
Jawad Iqbal, Donglei Yu, Maria Zubair, et al.
SAGE Open (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 88
Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress
Siying Li, Zaoyi Wang, Gang Liu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
Factors associated with phenoconversion of idiopathic rapid eye movement sleep behavior disorder: a prospective study
Yuan Yuan, Yuan Li, Hui Zhang, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, et al.
Neurologic Clinics (2025)
Closed Access | Times Cited: 1
The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective
Fan Zhang, Yuxian Liu, Yun Zhu, et al.
Journal of Nutrition (2025)
Closed Access | Times Cited: 1
Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth
Lydia Reznichenko, Tamar Amit, Moussa B. H. Youdim, et al.
Journal of Neurochemistry (2005) Vol. 93, Iss. 5, pp. 1157-1167
Closed Access | Times Cited: 146
Studying Toxicants as Single Chemicals: Does this Strategy Adequately Identify Neurotoxic Risk?
Deborah A. Cory‐Slechta
NeuroToxicology (2005) Vol. 26, Iss. 4, pp. 491-510
Closed Access | Times Cited: 131
Genetics of Parkinson disease
Nathan Pankratz, Tatiana Foroud
Genetics in Medicine (2007) Vol. 9, Iss. 12, pp. 801-811
Open Access | Times Cited: 119
Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease
Annadurai Anandhan, Kuppusamy Tamilselvam, Thangaiyan Radhiga, et al.
Brain Research (2011) Vol. 1433, pp. 104-113
Closed Access | Times Cited: 106
Pathophysiological roles for purines
Micaela Morelli, Anna R. Carta, Anil Kachroo, et al.
Progress in brain research (2010), pp. 183-208
Open Access | Times Cited: 88
Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma
Caroline Ménard, Stéphane Bastianetto, Rémi Quirion
Frontiers in Cellular Neuroscience (2013) Vol. 7
Open Access | Times Cited: 80
Examining the Relationship between Head Trauma and Neurodegenerative Disease: A Review of Epidemiology, Pathology and Neuroimaging Techniques
Mark H Sundman, Eric E. Hall, Nan‐kuei Chen
Journal of Alzheimer’s Disease & Parkinsonism (2014) Vol. 04, Iss. 01
Open Access | Times Cited: 79
Tea Polyphenols in Parkinson’s Disease
Mario Caruana, Neville Vassallo
Advances in experimental medicine and biology (2015), pp. 117-137
Closed Access | Times Cited: 76
Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies
Gabriela Henrı́quez, Alejandra Gomez‐Cadena, Erick Guerrero, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 19, pp. 2915-2934
Closed Access | Times Cited: 64
Association between tea consumption and depressive symptom among Chinese older adults
Ke Shen, Bin Zhang, Qiushi Feng
BMC Geriatrics (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 62
Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
Ryuuta Fukutomi, Tomokazu Ohishi, Yu Koyama, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 415-415
Open Access | Times Cited: 52
Smoking and tea consumption delay onset of Parkinson's disease
Boris Kandinov, Nir Giladi, Amos D. Korczyn
Parkinsonism & Related Disorders (2008) Vol. 15, Iss. 1, pp. 41-46
Closed Access | Times Cited: 95
Intra- and interspecific mineral composition variability of commercial instant coffees and coffee substitutes: Contribution to mineral intake
Marta Oliveira, Susana Casal, Simone Morais, et al.
Food Chemistry (2011) Vol. 130, Iss. 3, pp. 702-709
Open Access | Times Cited: 78
Intake of Japanese and Chinese teas reduces risk of Parkinson’s disease
Keiko Tanaka, Yoshihiro Miyake, Wakaba Fukushima, et al.
Parkinsonism & Related Disorders (2011) Vol. 17, Iss. 6, pp. 446-450
Closed Access | Times Cited: 69
Plant Polyphenols as Antioxidants Influencing the Human Health
Sanda Vladimir-Kneevi, Biljana Blaekovi, Maja Bival, et al.
InTech eBooks (2012)
Open Access | Times Cited: 58
A Comprehensive Overview of the Risks and Benefits of Coffee Consumption
L. Kirsty Pourshahidi, Luciano Navarini, M. Petracco, et al.
Comprehensive Reviews in Food Science and Food Safety (2016) Vol. 15, Iss. 4, pp. 671-684
Open Access | Times Cited: 50
Neuroprotection in Parkinson’s disease: facts and hopes
András Salamon, Dénes Zádori, László Szpisjak, et al.
Journal of Neural Transmission (2019) Vol. 127, Iss. 5, pp. 821-829
Open Access | Times Cited: 50
Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions
Song Li, Jie Dong, Cheng Cheng, et al.
Journal of Neural Transmission (2016) Vol. 123, Iss. 11, pp. 1279-1299
Closed Access | Times Cited: 48

Scroll to top